Strategic alliance announced for neurometabolomics research

Agilent Technologies have announced a collaboration with Daegu Gyeongbuk Institute of Science and Technology for neurometabolomics research.

Agilent Technologies, a global measurement specialist company, and Daegu Gyeongbuk Institute of Science and Technology (DGIST; Daegu, South Korea), a government-funded institute, have recently announced their collaboration for neurometabolomics research.

The collaboration will see DGIST’s new research center utilize Aglient Technologies’ bioanalytical instruments to identify biomarkers for detection and diagnosis of brain diseases.

Eun-Kyoung Kim, DGIST research center director, commented on the collaboration, “The Neurometabolomics Excellence Research Center will help sharpen South Korea’s edge in brain science and allow DGIST to contribute significantly to world-leading research.” Kim continued, “By working with Agilent, we can continue to spearhead developments and research in brain science.”

Rod Minett, general manager of Agilent Technologies’ life sciences business in South Korea and the South Asia Pacific region, explained the importance of the collaboration, “The brain is arguably the most important organ in the human body, and Agilent supports the quest to help scientific and medical communities further neuroscience discovery for the good of mankind.”

Source: Agilent Technologies and Daegu Gyeongbuk Institute of Science and Technology collaborate on neurometabolomics research.